Back to AA Arax Advisory Partners

RCELRCEL

5 quarters

Position history for AAArax Advisory Partners's holdings in Avita Medical, Inc.

Yes. Arax Advisory Partners holds 1,573 shares of RCEL (Avita Medical), worth $18,451, as of its Q3 2026 13F filing. It reduced the position by 5,580 shares (-78.0%) from Q2 2026. Arax Advisory Partners has held RCEL since Q3 2025, across 5 quarterly 13F filings.

Current Value

$18,451

Current Shares

1,573

Total Value Change

+$16,198

Total Shares Change

+1,132

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
1,573
-78.0%
$18,4510.0%$11.73
0
2026-Q2
Increased
7,153
+237x
$29,5420.0%$4.13
31
2026-Q1
Increased
30
+200.0%
$1110.0%$3.70
12
2025-Q4
Decreased
10
-97.7%
$350.0%$3.45
0
2025-Q3
New
441
—
$2,2530.0%$5.11
18

Optional analytics helps us improve. How it’s used